Trial Outcomes & Findings for High Pain Intervention in Cesarean Sections (NCT NCT01298778)
NCT ID: NCT01298778
Last Updated: 2018-09-10
Results Overview
to determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces acute post-delivery pain (24 hour evoked pain post delivery). The scale utilized was a 100mm sliding VAS, where 0mm=no pain up to 100mm-worst pain imaginable.
COMPLETED
NA
69 participants
24 hour
2018-09-10
Participant Flow
Participants were approached during the pre-anesthesia evaluation regarding their interest in the study. Once consent was signed, subjects completed their pre-surgery questionnaires. On the day of surgery, I/E criteria were re-reviewed for confirmed enrollment for study.A total of 74 were consented with 69 randomized, with 60 completing the study.
Participant milestones
| Measure |
Standard of Care
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Overall Study
STARTED
|
33
|
36
|
|
Overall Study
COMPLETED
|
30
|
30
|
|
Overall Study
NOT COMPLETED
|
3
|
6
|
Reasons for withdrawal
| Measure |
Standard of Care
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Overall Study
Lost to Follow-up
|
2
|
3
|
|
Overall Study
Incorrect use of VAS
|
1
|
0
|
|
Overall Study
Withdrawal by Subject
|
0
|
1
|
|
Overall Study
Protocol Violation
|
0
|
1
|
|
Overall Study
not meet inclusion/exclusion criteria
|
0
|
1
|
Baseline Characteristics
High Pain Intervention in Cesarean Sections
Baseline characteristics by cohort
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
Total
n=60 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
30 Participants
n=5 Participants
|
30 Participants
n=7 Participants
|
60 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
30 Participants
n=5 Participants
|
30 Participants
n=7 Participants
|
60 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
30 participants
n=5 Participants
|
30 participants
n=7 Participants
|
60 participants
n=5 Participants
|
|
Height-cm
|
163 cm
STANDARD_DEVIATION 6 • n=5 Participants
|
164 cm
STANDARD_DEVIATION 6 • n=7 Participants
|
163.3 cm
STANDARD_DEVIATION 6 • n=5 Participants
|
|
Weight-kg
|
88 kg
STANDARD_DEVIATION 17 • n=5 Participants
|
92 kg
STANDARD_DEVIATION 19 • n=7 Participants
|
89.7 kg
STANDARD_DEVIATION 17.7 • n=5 Participants
|
|
Gestational Age-weeks
|
39 weeks gestation
STANDARD_DEVIATION 0.3 • n=5 Participants
|
39 weeks gestation
STANDARD_DEVIATION 0.7 • n=7 Participants
|
39 weeks gestation
STANDARD_DEVIATION 0.5 • n=5 Participants
|
|
Parity
|
1 number previous deliveries
n=5 Participants
|
1 number previous deliveries
n=7 Participants
|
1 number previous deliveries
n=5 Participants
|
|
Previous Cesarean Section
|
27 Participants
n=5 Participants
|
24 Participants
n=7 Participants
|
51 Participants
n=5 Participants
|
|
ASA class
|
2 units on a scale
n=5 Participants
|
2 units on a scale
n=7 Participants
|
2 units on a scale
n=5 Participants
|
PRIMARY outcome
Timeframe: 24 hourto determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces acute post-delivery pain (24 hour evoked pain post delivery). The scale utilized was a 100mm sliding VAS, where 0mm=no pain up to 100mm-worst pain imaginable.
Outcome measures
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Severity of Acute Pain
|
46 mm
Standard Deviation 25
|
31 mm
Standard Deviation 17
|
SECONDARY outcome
Timeframe: 2 monthsto determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces persistent pain up to 2 months post delivery.
Outcome measures
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Incidence of Persistent Pain
|
13 percentage of participants
|
10 percentage of participants
|
SECONDARY outcome
Timeframe: 24 hourresting pain, worst pain
Outcome measures
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Pain
resting pain score over 24 hrs
|
19 units on a scale, 0 -none, 100-worst
Interval 0.0 to 33.0
|
4 units on a scale, 0 -none, 100-worst
Interval 0.0 to 10.0
|
|
Pain
worst pain score over 24 hrs
|
69 units on a scale, 0 -none, 100-worst
Interval 49.0 to 77.0
|
62 units on a scale, 0 -none, 100-worst
Interval 42.0 to 70.0
|
SECONDARY outcome
Timeframe: 24 hourtotal amount of analgesic consumption
Outcome measures
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Analgesic Consumption
IV PCA morphine
|
15 mg
Interval 11.0 to 32.0
|
15 mg
Interval 11.0 to 29.0
|
|
Analgesic Consumption
total 24 hr opioid use
|
21 mg
Interval 11.0 to 37.0
|
15 mg
Interval 13.0 to 33.0
|
SECONDARY outcome
Timeframe: 2 monthsto determine whether an intervention in women predicted to experience severe pain after cesarean delivery reduces postpartum depression up to 2 months post delivery.
Outcome measures
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Incidence of Depression
|
3 Participants
|
4 Participants
|
SECONDARY outcome
Timeframe: 24 hoursPopulation: VAS pain score of 0=no pain at all up to 100 being worst pain imaginable.
Outcome measures
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Average Pain Over 24 Hours
|
37 units on a scale
Standard Deviation 19
|
23 units on a scale
Standard Deviation 14
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24 hoursPopulation: percentage of patients with pruritis requiring treatment.
side effects-percentage of subjects requiring treatment
Outcome measures
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Pruritus
|
15 Participants
|
21 Participants
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 24hoursPopulation: percentage of patients reporting emetic symptoms requiring treatment
side effect potential with the increased dose of duramorph-percentage experiencing such symptoms
Outcome measures
| Measure |
Standard of Care
n=30 Participants
Spinal consists of duramorph 150 mcg combined with fentanyl and bupivacaine in conjunction with placebo capsules 2 PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Duramorph: Duramorph 150 mcg x 1 dose spinally + placebo capsules 2 PO q 6 hrs first 24 hrs postop x 4 doses
|
Acetaminophen and Increased Dose of Duramorph
n=30 Participants
Spinal consists of duramorph 300 mcg combined with fentanyl and bupivacaine in conjunction with Acetaminophen 1 Gm PO q 6 hrs x 4 doses in first 24 hrs postop. Ibuprofen given as standard of care.
Acetaminophen: Duramorph 300 mcg spinally + acetaminophen 1 GM q 6 hrs first 24 hrs postop x 4 doses
|
|---|---|---|
|
Emetic Symptoms
|
16 Participants
|
18 Participants
|
Adverse Events
Standard of Care
Acetaminophen and Increased Dose of Duramorph
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place